Brokerages Set Definitive Healthcare Corp. (NASDAQ:DH) PT at $5.72

Definitive Healthcare Corp. (NASDAQ:DH) has been given an average recommendation of “Hold” by the eleven brokerages that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $5.72.

A number of equities research analysts have recently commented on DH shares. BTIG Research started coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Finally, Stephens started coverage on Definitive Healthcare in a report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target for the company.

Definitive Healthcare Stock Up 5.8 %

DH opened at $4.36 on Friday. The firm has a market cap of $503.68 million, a P/E ratio of -1.41, a PEG ratio of 3.29 and a beta of 1.40. The business’s fifty day simple moving average is $4.37 and its 200 day simple moving average is $4.58. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33.

Insider Activity at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 14.84% of the stock is owned by insiders.

Hedge Funds Weigh In On Definitive Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in DH. Millennium Management LLC purchased a new stake in shares of Definitive Healthcare during the 2nd quarter valued at about $9,283,000. Massachusetts Financial Services Co. MA raised its stake in shares of Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after purchasing an additional 1,626,813 shares during the period. 272 Capital LP purchased a new stake in shares of Definitive Healthcare during the second quarter valued at approximately $3,480,000. State Street Corp boosted its stake in shares of Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after purchasing an additional 317,952 shares during the period. Finally, Marshall Wace LLP acquired a new stake in Definitive Healthcare during the 2nd quarter valued at $1,535,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.